IP Library Granted Patent US 8,475,417
Granted Patent B2
US 8,475,417 · App. 12/420,007 · Granted Jul 2, 2013

Assemblies for identifying a power injectable access port

Inventors: Kelly B. Powers (North Salt Lake, UT); Jim C. Beasley (Phoenix, AZ); Kevin W. Sheetz (Sandy, UT); Matthew M. Lowe (South Jordan, UT); Eddie K. Burnside (Bountiful, UT); Jay Gerondale (Newbury Park, CA)
Assignee: C. R. Bard, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,475,417
App. No.
12/420,007
Granted
Jul 2, 2013
Kind
B2
Abstract

Assemblies for identifying a power injectable vascular access port are described. One assembly includes a vascular access port, a first identifiable feature, a second identifiable feature, and a third identifiable feature. The first identifiable feature is incorporated into the access port and identifies the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port. The second identifiable feature is incorporated into the access port and identifies the access port as suitable for accommodating a pressure within the cavity of at least 35 psi. The third identifiable feature is separated from the access port and confirms that the implanted access port is both suitable for flowing fluid at a rate of at least 1 milliliter per second through the access port and for accommodating a pressure within the cavity of at least 35 psi.

Claims (32)

1. An assembly for identifying a power injectable vascular access port, comprising:

a vascular access port comprising a body defining a cavity, a septum, and an outlet in communication with the cavity;

a first identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the first feature identifying the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port;

a second identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the second feature identifying the access port as suitable for accommodating a pressure within the cavity of at least 35 psi, wherein one of the first and second features is a radiographic marker perceivable via x-ray; and

a third identifiable feature separated from the subcutaneously implanted access port, the third feature confirming that the implanted access port is both suitable for flowing fluid at a rate of at least 1 milliliter per second through the access port and for accommodating a pressure within the cavity of at least 35 psi.

2. The assembly according to claim 1 , wherein the other of the first and second features is a structural feature of the body or septum of the access port perceivable via palpation.

3. The assembly according to claim 2 , wherein the structural feature comprises a body having a particular geometric shape.

4. The assembly according to claim 1 , wherein the radiographic marker is a radiographic pattern included in the septum of the access port.

5. The assembly according to claim 1 , wherein the radiographic marker is one or more radiographic letters.

6. The assembly according to claim 1 , wherein the third feature comprises visually perceptible information provided on an element selected from the group consisting essentially of a key chain, a bracelet, a wrist band, a sticker provided on a patient's chart, a patientID card, a label provided on packaging of the access port, and combinations thereof.

7. The assembly according to claim 1 , wherein the third feature is incorporated in an infusion set packaged with the vascular access port.

8. An assembly for identifying a power injectable vascular access port, comprising:

a vascular access port comprising a body defining a cavity, a septum, and an outlet in communication with the cavity;

a first identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the first feature identifying the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port;

a second identifiable feature incorporated into the access port separate from the first identifiable feature, the second feature perceivable following subcutaneous implantation of the access port to identify the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port, wherein one of the first and second features is a radiographic marker perceivable via x-ray; and

a third identifiable feature separated from the subcutaneously implanted access port, the third feature confirming that the implanted access port is suitable for flowing fluid at a rate of at least 1 milliliter per second through the access port.

9. The assembly according to claim 8 , wherein the other of the first and second features is a structural feature of the body or septum of the access port perceivable via palpation.

10. The assembly according to claim 9 , wherein the structural feature comprises a body having a particular geometric shape.

11. The assembly according to claim 8 , wherein the radiographic marker is a radiographic pattern included in the septum of the access port.

12. The assembly according to claim 8 , wherein the radiographic marker is one or more radiographic letters.

13. The assembly according to claim 8 , wherein the third feature comprises visually perceptible information provided on an element selected from the group consisting essentially of a key chain, a bracelet, a wrist band, a sticker provided on a patient's chart, a patient ID card, a label provided on packaging of the access port, and combinations thereof.

14. The assembly according to claim 8 , wherein the third feature is incorporated in an infusion set packaged with the vascular access port.

15. An assembly for identifying a power injectable vascular access port, comprising:

a vascular access port comprising a body defining a cavity, a septum, and an outlet in communication with the cavity;

a first identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the first feature identifying the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port;

a second identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the second feature identifying the access port as suitable for accommodating a pressure within the cavity of at least 35 psi, wherein one of the first and second features is an RFID tag; and

a third identifiable feature separated from the subcutaneously implanted access port, the third feature confirming that the implanted access port is both suitable for flowing fluid at a rate of at least 1 milliliter per second through the access port and for accommodating a pressure within the cavity of at least 35 psi.

16. An assembly for identifying a power injectable vascular access port, comprising:

a vascular access port comprising a body defining a cavity, a septum, and an outlet in communication with the cavity;

a first identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the first feature identifying the access port as suitable for flowing fluid at a fluid flow rate of at least 1 milliliter per second through the access port;

a second identifiable feature incorporated into the access port perceivable following subcutaneous implantation of the access port, the second feature identifying the access port as suitable for accommodating a pressure within the cavity of at least 35 psi, wherein one of the first and second features is an ultrasound-detectable feature; and

a third identifiable feature separated from the subcutaneously implanted access port, the third feature confirming that the implanted access port is both suitable for flowing fluid at a rate of at least 1 milliliter per second through the access port and for accommodating a pressure within the cavity of at least 35 psi.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 20, 2017
From: C. R. BARD, INC.
To: BARD PERIPHERAL VASCULAR, INC.
Reel/Frame 043058/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2009
From: POWERS, KELLY B.; BEASLEY, JIM C.; SHEETZ, KEVIN W.; LOWE, MATTHEW; BURNSIDE, EDDIE K.; GERONDALE, JAY D.
To: C. R. BARD, INC.
Reel/Frame 022673/0854 →
Continuity (4)
Continuation 11380124 · Apr 25, 2006
Provisional Application 60737466 · Nov 15, 2005
Provisional Application 60675309 · Apr 27, 2005
Related Publication 20090227951A1 · Sep 10, 2009